Literature DB >> 21565676

Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.

Angela Boldo1, William B White.   

Abstract

Oral contraceptives and postmenopausal hormone therapy may induce hypertension through multiple mechanisms, including sodium and volume retention. Numerous studies have shown significant increases in blood pressure (BP) with the chronic administration of oral contraceptives as well as reversibility with discontinuation. The effects of different classes of oral contraceptive agents and hormonal replacement therapy on BP and associated effects on other cardiovascular risk factors are covered in this article. Novel hormonal replacement therapy that lowers BP is also discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565676     DOI: 10.1016/j.ecl.2011.01.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  17 in total

Review 1.  Hypertension in Athletes and Active Populations.

Authors:  Kevin T Schleich; M Kyle Smoot; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

Review 2.  Neurovascular control of blood pressure is influenced by aging, sex, and sex hormones.

Authors:  Sarah E Baker; Jacqueline K Limberg; Sushant M Ranadive; Michael J Joyner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-16       Impact factor: 3.619

3.  Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.

Authors:  Romana Dmitrovic; Allen R Kunselman; Richard S Legro
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

4.  Lack of effect of ovarian cycle and oral contraceptives on baroreceptor and nonbaroreceptor control of sympathetic nerve activity in healthy women.

Authors:  Holly R Middlekauff; Jeanie Park; Jeffrey A Gornbein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

Review 5.  Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.

Authors:  Ronée E Harvey; Kirsten E Coffman; Virginia M Miller
Journal:  Womens Health (Lond)       Date:  2015-03

6.  Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4.

Authors:  Kehinde Samuel Olaniyi; Lawrence Aderemi Olatunji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-01       Impact factor: 3.000

7.  Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in Women.

Authors:  Sarah E Baker; Jacqueline K Limberg; Gabrielle A Dillon; Timothy B Curry; Michael J Joyner; Wayne T Nicholson
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 8.  Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

Authors:  Anjli Maroo; Johnny Chahine
Journal:  Curr Heart Fail Rep       Date:  2018-06

9.  Greater Influence of Aerobic Fitness on Autonomic Support of Blood Pressure in Young Women Than in Older Women.

Authors:  Sarah E Baker; Jacqueline K Limberg; Zachariah M Scruggs; Timothy B Curry; Wayne T Nicholson; Jill N Barnes; Michael J Joyner
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

10.  Oral Contraceptive Use, Muscle Sympathetic Nerve Activity, and Systemic Hemodynamics in Young Women.

Authors:  Ronee E Harvey; Emma C Hart; Nisha Charkoudian; Timothy B Curry; Jason R Carter; Qi Fu; Christopher T Minson; Michael J Joyner; Jill N Barnes
Journal:  Hypertension       Date:  2015-06-22       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.